A Study of LY900014 in Participants With Type 1 Diabetes
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/6/2018 |
| Start Date: | July 17, 2017 |
| End Date: | September 5, 2019 |
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
The main purpose of this study is to evaluate the efficacy of the study drug LY900014
compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in
adults with type 1 diabetes (T1D).
compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in
adults with type 1 diabetes (T1D).
Inclusion Criteria:
- Have T1D for at least 1 year prior to screening and continuously using insulin for at
least 1 year.
- HbA1c of ≥7.0 and ≤9.5%.
- Use insulin lispro, insulin aspart, or insulin glulisine as prandial insulin.
- Use insulin glargine, insulin detemir, insulin degludec, or neutral protamine Hagedorn
(NPH) insulin as basal insulin.
Exclusion Criteria:
- Have used other antihyperglycemic medications or therapies (inhaled, oral or
injectable) within 90-days of screening.
- Have had more than 1 severe hypoglycemic episode within 6 months of screening.
- Have had more than 1 hospitalization related to hyperglycemia or diabetic ketoacidosis
within 6 months of screening.
- Have clinically significant gastrointestinal disease.
We found this trial at
13
sites
New York, New York 10016
Principal Investigator: Susan Zweig
Phone: 212-480-3333
Click here to add this to my saved trials
1200 S Cedar Crest Blvd
Allentown, Pennsylvania 18103
Allentown, Pennsylvania 18103
(610) 402-8000
Principal Investigator: Marc Vengrove
Phone: 610-402-9543
Lehigh Valley Hospital At Lehigh Valley Health Network, we continually go the extra mile to...
Click here to add this to my saved trials
Click here to add this to my saved trials
Escondido, California 92026
Principal Investigator: T S Bailey
Phone: 760-466-1530
Click here to add this to my saved trials
Greenville, North Carolina 27834
Principal Investigator: Mark Warren
Phone: 252-413-6392
Click here to add this to my saved trials
3901 Rainbow Blvd
Kansas City, Kansas 66160
Kansas City, Kansas 66160
(913) 588-5000
Principal Investigator: David Robbins
Phone: 913-588-2097
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials
Mentor, Ohio 44060
Principal Investigator: Daniel Weiss
Phone: 440-266-5000
Click here to add this to my saved trials
Mobile, Alabama 36608
Principal Investigator: Judson Menefee
Phone: 251-402-2101
Click here to add this to my saved trials
Morehead City, North Carolina 28557
Principal Investigator: Kathryn Lucas
Phone: 252222570025
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15224
Principal Investigator: Patricia Bononi
Phone: 412-683-4550
Click here to add this to my saved trials
215 Toll Gate Road
Warwick, Rhode Island 02886
Warwick, Rhode Island 02886
Principal Investigator: Sudhir Bansal
Phone: 401-732-6828
Click here to add this to my saved trials
Click here to add this to my saved trials
1907 Tradd Ct
Wilmington, North Carolina 28401
Wilmington, North Carolina 28401
(910) 799-5500
Principal Investigator: John Parker
Phone: 910-799-5500
PMG Research of Wilmington PMG Research of Wilmington has two offices situated in a 1...
Click here to add this to my saved trials